Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

310 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tissue microRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line Capecitabine and Oxaliplatin with or without Bevacizumab.
Boisen MK, Dehlendorff C, Linnemann D, Nielsen BS, Larsen JS, Osterlind K, Nielsen SE, Tarpgaard LS, Qvortrup C, Pfeiffer P, Holländer NH, Keldsen N, Hansen TF, Jensen BB, Høgdall EV, Jensen BV, Johansen JS. Boisen MK, et al. Among authors: johansen js. PLoS One. 2014 Oct 15;9(10):e109430. doi: 10.1371/journal.pone.0109430. eCollection 2014. PLoS One. 2014. PMID: 25329796 Free PMC article.
Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer.
Dehn H, Høgdall EV, Johansen JS, Jørgensen M, Price PA, Engelholm SA, Høgdall CK. Dehn H, et al. Among authors: johansen js. Acta Obstet Gynecol Scand. 2003 Mar;82(3):287-93. doi: 10.1034/j.1600-0412.2003.00010.x. Acta Obstet Gynecol Scand. 2003. PMID: 12694127 Free article.
Serum YKL-40, a new prognostic biomarker in cancer patients?
Johansen JS, Jensen BV, Roslind A, Nielsen D, Price PA. Johansen JS, et al. Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):194-202. doi: 10.1158/1055-9965.EPI-05-0011. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16492905 Review.
Is YKL-40 a new therapeutic target in cancer?
Johansen JS, Jensen BV, Roslind A, Price PA. Johansen JS, et al. Expert Opin Ther Targets. 2007 Feb;11(2):219-34. doi: 10.1517/14728222.11.2.219. Expert Opin Ther Targets. 2007. PMID: 17227236 Review.
YKL-40 tissue expression and plasma levels in patients with ovarian cancer.
Høgdall EV, Ringsholt M, Høgdall CK, Christensen IJ, Johansen JS, Kjaer SK, Blaakaer J, Ostenfeld-Møller L, Price PA, Christensen LH. Høgdall EV, et al. Among authors: johansen js. BMC Cancer. 2009 Jan 9;9:8. doi: 10.1186/1471-2407-9-8. BMC Cancer. 2009. PMID: 19134206 Free PMC article.
Plasma YKL-40: a potential new cancer biomarker?
Johansen JS, Schultz NA, Jensen BV. Johansen JS, et al. Future Oncol. 2009 Sep;5(7):1065-82. doi: 10.2217/fon.09.66. Future Oncol. 2009. PMID: 19792974 Review.
310 results